" /> Razoxane - CISMeF





Preferred Label : Razoxane;

NCIt related terms : ICRF 159; Razoxin;

NCIt definition : An orally bioavailable bis-dioxopiperazine and a derivative of the chelating agent ethylenediaminetetraacetic acid (EDTA) with antineoplastic, antiangiogenic, and antimetastatic activities. Razoxane specifically inhibits the enzyme topoisomerase II without inducing DNA strand breaks, which may result in the inhibition of DNA synthesis and cell division in the premitotic and early mitotic phases of the cell cycle. This agent may also exhibit antiangiogenic and antimetastatic activities although the precise molecular mechanisms of these actions are unknown.;

UNII : 5AR83PR647;

InChIKey : BMKDZUISNHGIBY-UHFFFAOYSA-N;

CAS number : 21416-87-5; 21416-67-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 21416-87-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 21416-67-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Razoxin;

Molecule name : ICRF 159; ICRF-159; ICI 59118;

Chemical formula : C11H16N4O4;

NSC code : 129943;

ChEBI ID : CHEBI:50225;

Codes from synonyms : NSC0129943;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.